Variable indoleamine 2,3‐dioxygenase expression in acral/mucosal melanoma and its possible link to immunotherapy - Iga, Natsuko; Otsuka, Atsushi; Hirata, Masahiro; Kataoka, Tatsuki R.; Irie, Hiroyuki; Nakashima, Chisa; Matsushita, Shigeto; Uchi, Hiroshi; Yamamoto, Yuki; Funakoshi, Takeru; Fujisawa, Yasuhiro; Yoshino, Koji; et al. (Cancer science, 2019)
Keywords: 3‐dioxygenase; Aged; Antigens; Asian People; Automation; Biomarkers; checkpoint inhibitor; Cloning; CTLA-4 Antigen - antagonists & inhibitors; Dioxygenase; Female; Humans; IDO; Immune checkpoint inhibitors; Immunohistochemistry; Immunotherapy; indoleamine 2; Indoleamine-Pyrrole 2,3,-Dioxygenase - metabolism; Japan; Kaplan-Meier Estimate; Laboratories; Ligands; Male; Medical prognosis; Melanoma; Melanoma - enzymology; Melanoma - mortality; Melanoma - pathology; Melanoma - therapy; Middle Aged; Mucosa; Mutation; Original; Patients; PD-1 protein; PD-L1 protein; PD‐1; Programmed Cell Death 1 Receptor - metabolism; Progression-Free Survival; Proportional Hazards Models; Proto-Oncogene Proteins B-raf - genetics; Regression analysis; Skin Neoplasms - enzymology; Skin Neoplasms - mortality; Skin Neoplasms - pathology; Skin Neoplasms - therapy; Survival; Tumors; Japan; indoleamine 2; melanoma; IDO; PD-1; 3-dioxygenase; checkpoint inhibitor